A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.
Sevil E. Bavbek
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Sanofi
Honoraria - GlaxoSmithKline; Novartis; Pfizer; Sanofi
Zafar Malik
Honoraria - advisory board; Sponsorship to attend ASCO-GU meeting
Giuseppe Di Lorenzo
No relevant relationships to disclose
Hans-Jorg Scholz
No relevant relationships to disclose
Inge M van Oort
No relevant relationships to disclose
Siobhan Ng
Consultant or Advisory Role - Australian cabazitaxel advisory board (U)
Other Remuneration - Sponsorship to attend ASCO meeting
Mustafa Ozguroglu
Consultant or Advisory Role - ProStrtic
Honoraria - Advisory board x 2
Winald R. Gerritsen
Consultant or Advisory Role - Sanofi
Stefan Mueller
No relevant relationships to disclose
Timo Marttila
Consultant or Advisory Role - Sanofi
Luis Antón-Aparicio
No relevant relationships to disclose
Luis M. Anton-Aparicio
Disclosure not yet available
Peter Albers
Honoraria - Sanofi
Juergen Gschwend
No relevant relationships to disclose
Samira Bensfia
Employment or Leadership Position - Sanofi
Evelyne B Ecstein-Fraïssé
Employment or Leadership Position - Sanofi
Sergio Bracarda
Consultant or Advisory Role - Johnson & Johnson; Sanofi
Honoraria - Sanofi
Axel Heidenreich
Consultant or Advisory Role - Astellas Pharma; Ipsen; Janssen-Cilag; Sanofi ; Takeda
Honoraria - Amgen; Astellas Pharma; Bayer; GlaxoSmithKline; Ipsen; Janssen-Cilag; Pfizer